![Featured Image For Debt Facility for Biopharmaceutical Company](assets/images-t1719606675/15172.jpeg)
Chapman served as counsel to a health care and life sciences hedge fund in a $10 million debt facility for a biopharmaceutical company. The debt facility will be used to repay an existing debt facility and support the company's build out of its manufacturing facility.